Precision Biosciences (DTIL) Profit After Tax (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Profit After Tax data on file, last reported at -$18.4 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 10.33% year-over-year to -$18.4 million in Q1 2026; TTM through Mar 2026 was -$44.5 million, a 102.33% decrease from a year earlier, with the FY2025 full-year figure at -$46.6 million, down 750.33% from the prior year.
• Profit After Tax for Q1 2026 stood at -$18.4 million, down from $19.2 million in the prior quarter.
• Over the last five years, Profit After Tax for DTIL reached as high as $32.7 million in Q2 2024 and fell as low as -$58.2 million in Q4 2022.
• Historically, Profit After Tax has averaged -$14.9 million across 5 years, with a median of -$17.7 million in 2024.
• Across the five-year window, Profit After Tax jumped 375.41% in 2024 and tumbled 339.46% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$58.2 million in 2022, then soared by 76.9% to -$13.4 million in 2023, then tumbled by 32.09% to -$17.7 million in 2024, then soared by 208.47% to $19.2 million in 2025, then tumbled by 195.81% to -$18.4 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$18.4 million in Q1 2026, $19.2 million in Q4 2025, and -$21.8 million in Q3 2025.